EUVIMEDEUVIMED entdecken
FallberichtOpen Access · CC BY-NC 4.0

Prostate cancer recurring as small‐cell carcinoma with a BRCA2 somatic mutation

Ryo Yabusaki iD, Koji Yoshimura iD, Keisei Taku, Makoto Suzuki

IJU Case Reports · 2022-11 · 5 (6) · 489-492

DOI: 10.1002/iju5.12523 ↗

Kurz gefasst

Fallbericht in der Zeitschrift IJU Case Reports, online erschienen am 12.08.2022. Verfasst von Ryo Yabusaki und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology Shizuoka General Hospital Shizuoka Japan. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 18 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Small‐cell carcinoma of the prostate has a poor prognosis, and treatment options for the refractory disease are unclear. Case presentation A 68‐year‐old man with prostate cancer was referred to our hospital. He was treated with combined androgen blockade (bicalutamide and degarelix acetate). The disease progressed to castration‐resistant prostate cancer, but with additional treatment, prostate‐specific antigen levels remained below 0.02 ng/mL. However, computed tomography revealed enlarged right inguinal lymph nodes; moreover, his neuron‐specific enolase levels were elevated. Histopathologic analysis of a biopsied lymph node confirmed small‐cell carcinoma. After administering cytotoxic chemotherapy (etoposide plus cisplatin and amrubicin), the patient temporarily improved before relapsing. After genetic testing of the biopsy specimen revealed a BRCA2 deletion, we administered the oral PARP‐2 inhibitor olaparib, which has achieved partial remission for 8 months.

Conclusion

PARP‐2 inhibition may improve the survival of patients with BRCA2 ‐positive small‐cell carcinoma of the prostate.

Schlagwörter

Stichwörter der Autor:innen

BRCA2 genePARP inhibitorprostate cancersmall‐cell carcinoma

Autor:innen und Institutionen

  • Department of Urology Shizuoka General Hospital Shizuoka Japan.
  • Department of Oncology Shizuoka General Hospital Shizuoka Japan.
  • Department of Pathology Shizuoka General Hospital Shizuoka Japan.

ORCID-Profile: Ryo Yabusaki, Koji Yoshimura

Zitieren

APA

Yabusaki, R., Yoshimura, K., Taku, K., & Suzuki, M. (2022). Prostate cancer recurring as small‐cell carcinoma with a BRCA2 somatic mutation. IJU Case Reports, 5(6), 489-492. https://doi.org/10.1002/iju5.12523

Vancouver

Yabusaki R, Yoshimura K, Taku K, Suzuki M. Prostate cancer recurring as small‐cell carcinoma with a BRCA2 somatic mutation. IJU Case Reports. 2022;5(6):489-492. doi:10.1002/iju5.12523

BibTeX
@article{Yabusaki2022,
  author = {Yabusaki, Ryo and Yoshimura, Koji and Taku, Keisei and Suzuki, Makoto},
  title = {Prostate cancer recurring as small‐cell carcinoma with a BRCA2 somatic mutation},
  journal = {IJU Case Reports},
  year = {2022},
  volume = {5},
  number = {6},
  pages = {489--492},
  doi = {10.1002/iju5.12523}
}
Kostenlos starten →